Strategies to increase nitric oxide signalling in cardiovascular disease

JO Lundberg, MT Gladwin, E Weitzberg - Nature reviews Drug …, 2015 - nature.com
Nitric oxide (NO) is a key signalling molecule in the cardiovascular, immune and central
nervous systems, and crucial steps in the regulation of NO bioavailability in health and …

Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview

LJ Ignarro, C Napoli, J Loscalzo - Circulation research, 2002 - Am Heart Assoc
Nitric oxide (NO) mediates multiple physiological and pathophysiological processes in the
cardiovascular system. Pharmacological compounds that release NO have been useful tools …

The opposing roles of NO and oxidative stress in cardiovascular disease

RH Ritchie, GR Drummond, CG Sobey… - Pharmacological …, 2017 - Elsevier
Nitric oxide (NO) plays a pivotal role in the maintenance of cardiovascular homeostasis. A
reduction in the bioavailability of endogenous NO, manifest as a decrease in the production …

Nitric oxide signalling in cardiovascular health and disease

C Farah, LYM Michel, JL Balligand - Nature Reviews Cardiology, 2018 - nature.com
Nitric oxide (NO) signalling has pleiotropic roles in biology and a crucial function in
cardiovascular homeostasis. Tremendous knowledge has been accumulated on the …

Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis

R Schulz, T Rassaf, PB Massion, M Kelm… - Pharmacology & …, 2005 - Elsevier
Nitric oxide synthases (NOS) are the enzymes responsible for nitric oxide (NO) generation.
To date, 3 distinct NOS isoforms have been identified: neuronal NOS (NOS1), inducible NOS …

Nitric oxide synthases, S-nitrosylation and cardiovascular health: from molecular mechanisms to therapeutic opportunities

AV Treuer, DR Gonzalez - Molecular medicine reports, 2015 - spandidos-publications.com
The understanding of nitric oxide (NO) signaling has grown substantially since the
identification of endothelial derived relaxing factor (EDRF). NO has emerged as a ubiquitous …

Blocking NO synthesis: how, where and why?

P Vallance, J Leiper - Nature Reviews Drug Discovery, 2002 - nature.com
Nitric oxide (NO) is a key physiological mediator, and the association of disordered NO
generation with many pathological conditions has led to much interest in pharmacologically …

[PDF][PDF] Nitric oxide signalling in the regulation of cardiovascular and platelet function

E Gkaliagkousi, A Ferro - Front Biosci, 2011 - academia.edu
Nitric oxide (NO) exerts important protective actions on the cardiovascular system.
Generated from L-arginine by the action of endothelial (or type 3) nitric oxide synthase …

Nitric oxide–releasing drugs

C Napoli, LJ Ignarro - Annual review of pharmacology and …, 2003 - annualreviews.org
Pharmacological compounds that release nitric oxide (NO) have been useful tools for
evaluating the broad role of NO in physiology and therapeutics. NO deficiency has been …

Pathophysiological relevance of NO signaling in the cardiovascular system: novel insight from mice lacking all NO synthases

M Tsutsui, H Shimokawa, Y Otsuji… - Pharmacology & …, 2010 - Elsevier
Nitric oxide (NO) exerts a variety of biological actions under both physiological and
pathological conditions. NO is synthesized by three distinct NO synthase (NOS) isoforms …